Skip to main content

Advertisement

Fig. 2 | Cardiovascular Diabetology

Fig. 2

From: Treatment with high-dose n-3 PUFAs has no effect on platelet function, coagulation, metabolic status or inflammation in patients with atherosclerosis and type 2 diabetes

Fig. 2

Permeation coefficient (Ks), before (a) and after intervention (b); endogenous thrombin potential (ETP), before (c) and after intervention (d); platelet aggregation—5 mmol/L of arachidonic acid (PR AA) before (e) and after intervention (f) in placebo and n-3 PUFAs group. Horizontal line median; upper and lower margin of rectangle interquartile range, vertical line observation away from 1.5 quartiles

Back to article page